Fig. 1: The location and frequency of MYD88 mutations in CLL.
In total, 58 mutations were identified in 56 patients. Two patients had two concurrent mutations, one with N291S/T294P, another with F252I/M232T. TIR toll/Interleukin-1 receptor.
Fig. 1: The location and frequency of MYD88 mutations in CLL. | Blood Cancer Journal
